Steven Burke
Vermogen: 531 735 $ op 30-09-2026
Vermogen: 531 735 $ op 30-09-2026
Dr. Steven K.
Burke, MD, is a Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. He is on the Board of Directors at SCYNEXIS, Inc., AbFero Pharmaceuticals, Inc. and LeukoSight, Inc. Dr. Burke was previously employed as a Chief Medical Officer & Senior Vice President by Proteon Therapeutics, Inc., a Senior Vice President-Medical & Regulatory Affairs by Genzyme Corp., a Medical Director & VP-Clinical Research by GelTex Pharmaceuticals, Inc., an Associate Director-Clinical Research by Glaxo, Inc., and a Chief Medical Officer by Protara Therapeutics, Inc. He received his undergraduate degree from Harvard College and a doctorate degree from Weill Cornell Medical College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 547.098 ( 0,2% ) | 503 330 $ | 30-09-2026 | |
SCYNEXIS, INC. 0,06% | 18-09-2026 | 5.750 ( 0,06% ) | 28 405 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-06-2019 |
| SCYNEXIS, INC. | Directeur/Bestuurslid | 18-09-2026 |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Oprichter | - |
| PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau